Nathaniel Katz Selected Research

Nathaniel Katz Research Topics

Disease

34	Pain (Aches) 01/2021 - 07/2002
14	Chronic Pain 01/2021 - 07/2002
14	Low Back Pain (Lumbago) 11/2020 - 07/2002
7	Osteoarthritis 10/2017 - 07/2002
4	Opioid-Related Disorders (Opiate Addiction) 10/2020 - 07/2005
4	Neuralgia (Stump Neuralgia) 12/2018 - 07/2002
4	Substance-Related Disorders (Drug Abuse) 07/2017 - 02/2006
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2021 - 12/2016
2	Pancreatitis 10/2020 - 07/2005
2	Mental Disorders (Mental Disorder) 10/2020 - 07/2005
2	Hepatitis A (Hepatitis, Infectious) 10/2020 - 07/2005
2	Poisoning 10/2020 - 07/2005
2	Knee Osteoarthritis 11/2018 - 10/2017
2	Acute Pain 08/2018 - 12/2002
2	Cancer Pain 01/2018 - 12/2002
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2017 - 12/2016
2	Hip Osteoarthritis (Coxarthrosis) 07/2010 - 04/2010
1	Dizziness (Lightheadedness) 12/2018
1	Sleepiness 12/2018
1	Wounds and Injuries (Trauma) 12/2018
1	Burns 10/2017
1	Arthritis (Polyarthritis) 10/2017
1	Dysgeusia (Parageusia) 10/2017
1	Radiculopathy (Radiculopathy, Cervical) 09/2017
1	Alcoholism (Alcohol Abuse) 07/2017
1	Opiate Overdose 07/2017
1	Arthralgia (Joint Pain) 01/2017
1	Erythema 12/2016
1	Neoplasm Metastasis (Metastasis) 09/2015
1	Hyperalgesia 06/2015
1	Breakthrough Pain 02/2015
1	Paresthesia (Dysesthesia) 10/2013
1	Headache (Headaches) 10/2013
1	Nasopharyngitis 10/2013
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 07/2010
1	Infertility (Sterility) 02/2009
1	Osteoporosis 02/2009
1	Menstruation Disturbances 02/2009
1	Fatigue 02/2009
1	Erectile Dysfunction 02/2009
1	Hypogonadism (Hypergonadotropic Hypogonadism) 02/2009
1	Compression Fractures (Compression Fracture) 02/2009
1	Galactorrhea 02/2009
1	Dysmenorrhea (Menstrual Pain) 12/2002

Drug/Important Bio-Agent (IBA)

27	Opioid Analgesics (Opioids)IBA 10/2020 - 07/2002
12	Analgesics (Analgesic Drugs)IBA 01/2020 - 07/2002
4	Morphine (MS Contin)FDA LinkGeneric 11/2016 - 07/2004
3	NKTR-181IBA 11/2020 - 01/2019
3	Capsaicin (Zostrix)FDA Link 11/2018 - 12/2016
3	Nerve Growth Factor (NGF)IBA 09/2015 - 10/2011
3	rofecoxib (Vioxx)FDA Link 05/2004 - 07/2002
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2003 - 07/2002
2	Pregabalin (Lyrica)FDA Link 01/2021 - 12/2018
2	mu Opioid Receptors (mu Opioid Receptor)IBA 11/2020 - 01/2019
2	Prescription DrugsIBA 10/2020 - 07/2005
2	Naproxen (Naprosyn)FDA LinkGeneric 11/2018 - 10/2017
2	fulranumabIBA 01/2017 - 10/2013
2	tanezumabIBA 09/2015 - 10/2011
2	Naltrexone (ReVia)FDA LinkGeneric 07/2010 - 04/2010
2	naltrexone combination morphine FDA Link 07/2010 - 04/2010
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2002 - 07/2002
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	Opioid Receptors (Opioid Receptor)IBA 01/2018
1	mavatrepIBA 10/2017
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 09/2017
1	Antidepressive Agents (Antidepressants)IBA 07/2017
1	BenzodiazepinesIBA 07/2017
1	Buprenorphine (Subutex)FDA LinkGeneric 11/2016
1	Monoclonal AntibodiesIBA 09/2015
1	brassIBA 06/2015
1	Prostaglandins AIBA 02/2011
1	Opiate AlkaloidsIBA 07/2010
1	Abuse-Deterrent FormulationsIBA 01/2010
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2009
1	Gonadal Steroid Hormones (Sex Hormones)IBA 02/2009
1	salicylhydroxamic acid (SHAM)IBA 01/2009
1	Anesthetics (Anesthetic Agents)IBA 01/2009
1	Celecoxib (Celebrex)FDA Link 06/2007
1	valdecoxib (Bextra)FDA Link 06/2007
1	Oxymorphone (Numorphan)FDA LinkGeneric 01/2007
1	Sufentanil (Sufenta)FDA LinkGeneric 07/2004
1	Fentanyl (Sublimaze)FDA LinkGeneric 07/2004
1	Acetaminophen (Paracetamol)FDA LinkGeneric 05/2003
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2002
1	Illicit Drugs (Recreational Drugs)IBA 07/2002

Therapy/Procedure

9	Therapeutics 01/2017 - 07/2002
4	Pain Management 07/2017 - 12/2002
3	Analgesia 09/2015 - 07/2004
2	Spinal Cord Stimulation 01/2021 - 01/2021
1	Ambulatory Care (Outpatient Care) 10/2017
1	Intravenous Injections 09/2017
1	Diffuse Noxious Inhibitory Control 06/2015
1	Subcutaneous Injections 10/2013
1	Anesthesia 01/2009
1	Orthopedic Procedures 12/2002